Live
- Delhi Zoo to roll out membership plans
- Kotak Mahindra vows fix after RBI action
- Banks failing to tap fintech: Ashneer
- AAP major beneficiary of proceeds of crime, ED tells SC
- India aims for $1-trn goods export by 2030
- Swiggy to raise $1.2 bn via IPO
- Salesforce takes up CSR activity
- Vodafone Idea raises Rs 18K cr
- Mkts rise for fifth day in a row on banking, metal stocks surge
- HC directs MLA disqualification pleas to be sent to Speaker, adjourns hearing to April 29
Dr Reddy’s Lab Q2 profit up 69 pc at Rs 690 crore
Highlights
Dr Reddy’s Lab Q2 Profit Up 69 Per Cent At Rs 690 Crore. Drug major Dr Reddy’s Laboratories on Thursday reported a 69.41 per cent increase in consolidated net profit at Rs 690.25 crore for the second quarter ended September 30.
Drug major Dr Reddy’s Laboratories on Thursday reported a 69.41 per cent increase in consolidated net profit at Rs 690.25 crore for the second quarter ended September 30. The company had posted a profit of Rs 407.44 crore in the same period of the previous financial year.
Net sales rose to Rs 3,357.45 crore from Rs 2,880.85 crore a year earlier, Dr Reddy’s Laboratories said in a BSE filing. Revenue from the global generics segment grew 32 per cent to Rs 2,654.78 crore, driven by North America, Russia and other emerging markets, the company said.
Shares of Dr Reddy’s Laboratories were down 2.52 per cent at Rs 2,459.20 on the BSE in late afternoon trade.
Next Story
ADVERTISEMENT
